On June 3, Synnovis, a pathology laboratory serving several NHS organisations in South East London, was targeted by a ransomware attack.
This cyber incident has disrupted vital blood testing services, crucial for a range of medical treatments, and raised significant concerns over data security.
NHS England confirmed that a cybercriminal group, Qilin, published data online, claiming it was stolen from Synnovis.
The National Crime Agency (NCA) and the National Cyber Security Centre (NCSC) are currently working to authenticate the data and understand its contents.
A helpline has been established to address patient concerns, and NHS England urges patients to attend their appointments unless otherwise directed.
The attack has rendered some of the NHS's blood testing systems inoperable, causing substantial disruption to medical services in South East London.
Men can now have their blood pressure checked while visiting a barbershop. The NHS is extending its blood pressure screening services to different local
venues, including barbershops, mosques, and pharmacies. This initiative aims to address the increasing risk of strokes and heart attacks among men.
NHS staff's life-saving actions coincide with recent data indicating that high street pharmacies administered 149,865 blood pressure checks to individuals over
40 in May 2023. This marked a notable increase from the previous year's count of 58,345 in May 2022, the NHS said. "More than 1,300 heart attacks and strokes
could be prevented this year thanks to the high street checks."
"The total number of blood pressure checks delivered by pharmacy teams in the year to March was more than 1 million (1,053,278)," the NHS added.
Furthermore, the government has committed £645 million for a range of added pharmaceutical services. This includes a target of conducting 2.5 million extra blood
pressure checks annually at community pharmacies. This effort is estimated to avert over 1,350 cardiovascular events per year - equivalent to averting 113 heart
attacks and strokes each month.
Northern Ireland's health minister Robin Swann has condemned the act of violence experienced by pharmacy teams, stating such acts "will not be tolerated."
His statement follows an ugly incident that took place on Saturday (March 5) at the Teagues Pharmacy, Antrim Road in Belfast, Northern Ireland.
Conor McAreavey from Teagues Pharmacy told the BBC that on Saturday a man entered the shop at about 17:30 GMT and used a hammer to break through a Covid protection screen, and stabbed him in hand before fleeing the premises.
He added that such attacks on pharmacists had become a "trend".
Condemning the attack, Swann said: "Abuse or assaults of any kind on health and social care staff will not be tolerated. I was appalled to hear of the assault on the community pharmacist at the weekend.
The National Institute for Health and Care Excellence (NICE) has recommended icosapent ethyl also called Vazkepa manufactured by Amarin for adults who have cardiovascular disease with controlled LDL-C levels taking a statin.
It's final draft guidance is expected to be available on the July 20.
Nearly half a million people are expected to benefit from the first licensed treatment shown to reduce the risk of heart attacks and strokes in people with
controlled low-density lipoprotein cholesterol (LDL-C - sometimes called "bad" cholesterol) who are taking a statin and who have raised levels of triglycerides.
NICE said: "Clinical trial evidence suggests that for people with raised triglycerides who have LDL-C levels controlled by statins, and who have cardiovascular disease, icosapent ethyl reduces their risk of cardiovascular events by over a quarter compared with placebo.
Helen Knight, interim director of medicines evaluation at NICE, said: "Icosapent ethyl is the first licensed treatment of its kind for people who are at risk of heart attacks and strokes despite well controlled LDL cholesterol because they have raised blood fats. And although lifestyle changes, including diet and exercise, can help to reduce their risk, these may not work for everyone.
Community pharmacies are well placed to play a role in preventing deaths from cardiovascular disease (CVD) said Director of NHS Services.
The recent analysis by the British Heart Foundation (BHF) revealed that nearly 100,000 more people with cardiovascular disease than expected have died since the
start of the pandemic in England.
Latest figures show that the number of people waiting for time-sensitive cardiac care was at a record high of nearly 390,000 at the end of April in England.
Average ambulance response times for heart attacks and strokes have consistently been above 30 minutes since the beginning of 2022, and in December 2022 they even
breached 90 minutes. The target is 18 minutes, though the Government has set a new average target of 30 minutes over 2023/24.
Director of NHS Services, Alastair Buxton, said: "It is concerning to hear that there have been tens of thousands of preventable deaths from cardiovascular
disease (CVD) since the start of the COVID-19 pandemic. We share BHF's desire to see more action on preventing the causes of CVD and, subject to appropriate
funding being in place, community pharmacy teams are well placed to play a role in this.
The Pharmacists' Defence Association (PDA) has launched a brutal attack on some large pharmacy chains for full or part-day closures of some of their shops
throughout the UK.
It published an Open Letter on Tuesday (July 19) demanding urgent action "to protect patients by ensuring that essential community pharmacy services are provided
safely and consistently".
PDA chair Mark Koizol, who wrote the letter, went on to allege that many of those closure were "being orchestrated".
He wrote that the "pharmacist shortage" narrative cited as a reason for these closures was "very different" from "the reality experienced by our members", including
both employed and locum pharmacists.
"We have evidence to show that these closures are being announced up to four weeks in advance," Koizol claimed.
He gave examples of how a large company attempted to reduce the pre-agreed rate of locums and where this was not accepted, the shift was cancelled, resulting in the
pharmacy being closed for part or full day.
In partnership with the pharmaceutical company Boehringer Ingelheim, Leeds Teaching Hospitals Trust (LTHT) has recently established an innovative
cardiometabolic clinic.
The clinic focuses on reducing cardiovascular risk in people with diabetes who have recently been discharged from LTHT following a heart attack. It is delivered jointly by the cardiology department at Leeds General Infirmary and the diabetes services at the Trust.
This is a patient-centred approach to reducing that risk, with pharmacist-delivered clinics scheduled for six to eight weeks after the heart attack.
Stephen Wheatcroft, Professor of Cardiometabolic Medicine and Consultant Cardiologist at LTHT, said: "This is an exciting and innovative development, one of the
first in the country. Previously, Type 2 diabetic patients presenting with heart issues would have been treated by two separate specialty teams. This is the first time there has been a specific clinic combining the cardiac and diabetes team working together.
"We aim to reduce the risk for patients, with earlier multidisciplinary hospital care, to help discharged patients achieve better diabetes control, through improved medication support and optimisation, reducing the need for further treatment and future hospital stays. Overall, it will mean a better patient experience, with improved monitoring and information about treatment options, along with a reduction in waiting times for review in a specialist clinic."
The National Institute for Health and Care Excellence (NICE) has published a new diagnostic guidance to enhance CYP2C19 genotype testing to guide clopidogrel
use for patients who have suffered an ischemic stroke or transient ischemic attack.
Published in July, the diagnostic guidance also emphasised the vital role of pharmacists and pharmacies in the implementation of CYP2C19 genotype testing used to
guide prescribed antiplatelet medication.
According to the NICE guidance, pharmacists with their expertise in pharmacogenomics and patient medication management, will be integral in interpreting test
results and recommending appropriate antiplatelet therapy.
It also highlighted the need for close collaboration with other healthcare professionals to ensure effective implementation across various care settings for stroke
patients.
The diagnostics advisory committee, a standing advisory committee of NICE, agreed that it should be possible to gather samples for genotype testing at a location
that is convenient for the person having the test and highlighted the role of pharmacies as accessible locations for CYP2C19 genotype testing.The National Institute for Health and Care Excellence (NICE) has published a new diagnostic guidance to enhance CYP2C19 genotype testing to guide clopidogrel
use for patients who have suffered an ischemic stroke or transient ischemic attack.
Published in July, the diagnostic guidance also emphasised the vital role of pharmacists and pharmacies in the implementation of CYP2C19 genotype testing used to
guide prescribed antiplatelet medication.
According to the NICE guidance, pharmacists with their expertise in pharmacogenomics and patient medication management, will be integral in interpreting test
results and recommending appropriate antiplatelet therapy.
It also highlighted the need for close collaboration with other healthcare professionals to ensure effective implementation across various care settings for stroke
patients.
The d
The National Health Service (NHS) on Monday launched a new national campaign to find the 'missing millions' who could be living with undiagnosed high
blood pressure, often described as a 'silent killer'.
People are being warned that the condition rarely has any symptoms and it can lead to fatal heart attacks, strokes, kidney disease and vascular dementia, if
left untreated.
According to the NHS, high blood pressure affects an estimated 32 per cent of adults and approximately three in 10 of these remain undiagnosed, equating to
4.2 million people in England.
The NHS has expanded blood pressure checks in community pharmacies to include 2.5 million more tests as part of the Pharmacy First programme.
With the 'Get Your Blood Pressure Checked' campaign, the health service is encouraging those aged 40 years and over to get a free blood pressure test at a
participating pharmacy, for which they don't need to be booked in advance.
Health Minister Andrea Leadsom expressed confidence that this new drive will help to prevent the potentially "fatal consequences" of untreated high blood
pressure. She urged people to go to their local pharmacy to get their blood pressure checked, stating that it could be a "lifesaving trip."
You may get anxious or would feel nervous while speaking publically or in any tough situation. In some people, anxiety becomes so forceful that it starts to take over your lives. However, it is difficult to distinguish how anxiety converts to a disorder. Anxiety issue is seen in several other forms like social anxiety, phobia, panic attacks...
Iodine is most known for its relationship to the production of thyroid hormones. Not well known is that iodine also functions as a key antioxidant that protects cell membrane fatty acids from free radical attack.
A daily medication for high blood pressure could be replaced by an injection twice a year, if Queen Mary University and Barts Health NHS Trust succeed in their trail to investigate if an injection-based drug - Zilebesiran - could inhibit the production of a protein called angiotensinogen (AGT).
Scientists are to trial a world-first drug to treat high blood pressure that can be given by injection twice a year.
Professor Sir Nilesh Samani, medical director, British Heart Foundation, said: "This exciting trial could lead to good news for the millions of people across the UK with high blood pressure, many of whom need to take daily medication to lower their risk of heart attacks and strokes.
"The study will determine whether an injection given twice a year lowers blood pressure sufficiently over a prolonged period.
"If this proves to be the case, it may provide an alternative to taking daily pills for some patients."
The National Institute for Health and Care Excellence (NICE) has released conclusive draft guidance, suggesting Pfizer's Vydura (rimegepant) as a choice for
treating acute migraines in adults with or without aura.
However, there is a caveat. This recommendation applies exclusively to individuals with a prior history of migraines, meeting one of the following criteria:
At least 2 triptans were tried and they did not work well enough or
Triptans were contraindicated or not tolerated, and nonsteroidal anti-inflammatory drugs (NSAIDs) and paracetamol were tried but did not work well enough.
This drug was developed by the US-based Biohaven Pharmaceuticals, acquired by Pfizer in 2022, in an $11.6 billion deal. Nurtec ODT is the commercial name for the
drug in the US, while the European Union approved the drug under the name Vydura in April 2022.
NICE recommended rimegepant, an oral lyophilisate (dissolving wafer) and the first oral calcitonin gene-related peptide (CGRP) receptor antagonist for acute
migraine treatment, to be taken at the onset of a migraine attack.
Migraine affects one in seven people in the UK, often with a debilitating impact, Pfizer UK said in a statement. The condition entails symptoms such as head pain,
vomiting, nausea, altered vision, fatigue, and heightened sensitivity to light, sound, and odours.
Whether you believe it or not, following a vegan diet can be quite eventful for your body. For instance, it can help you lose weight, get a better body
structure, and so on.
However, is that all? You can get that by following a thorough exercise plan as well, no?
Well, yes, you can. Nevertheless, following a vegan diet plan can help you out in more than a single manner. Please keep reading this article till the end to know
more about it.
WHAT IS A VEGAN DIET?
As a vegan, you can eat dairy food, including cheese and milk, without any boundaries. If you want to get a little bit of protein, you may consume eggs (boiled or
in a gravy) too. Also, yes, plants are going to be an integral part of your diet plan too.
However, you won't be able to eat meat anymore. So, no chicken, mutton, or beef for the rest of your life. Instead, you will need to focus solely on plant-based
protein.
BENEFITS OF FOLLOWING A VEGAN DIET
A plant-based diet structure can be highly beneficial for your health. For example, it can -
LOWER YOUR BLOOD PRESSURE.
Hypertension, also known as high blood pressure, can increase your risk of a heart attack. It's also known to be a close counterpart of type-2 diabetes too.
Fortunately, though, the diet you follow can make quite a massive difference here. For example, following a vegan diet can help you reduce the amount of oily food
you're taking on a daily basis.
This, in turn, can decrease the amount of cholesterol in your blood and make it easier for you to lose weight. And, the less obese you are, the lower your blood
pressure will be.
As part of a new blueprint for primary care, the government today (May 9) announced an investment of £645 million over two years to expand community pharmacy
services in England.
In a statement, NHS England said: "For the first time ever, patients who need prescription medication will be able to get it directly from a pharmacy, without a
GP appointment, for seven common conditions including earache, sore throat, or urinary tract infections."
Prime minister Rishi Sunak hopes that the measures will help end the "all-too stressful wait on the end of the phone for patients" by freeing up 15 million slots at
doctors' surgeries over the next two years.
"We will end the 8am rush and expand the services offered by pharmacies, meaning patients can get their medication quickly and easily," he said
Almost half a million women will no longer need to speak to a practice nurse or GP to access oral contraception and will instead be able to pop into their local
pharmacy for it, according to the government announcement.
Blood checks for people suffering from moderate risk of heart attack or stroke conducted in community pharmacies will more than double from 900,000 last year to
2.5 million next year.
NHS chief executive Amanda Pritchard said the "ambitious package" would help transform how care is provided within the health service "with pharmacies playing a
central role in managing the nation's health including providing lifesaving checks and medication for common conditions for the first time.
All pharmacy businesses are reporting that they are struggling to find the registered professionals needed to open their pharmacies, clarified the Company
Chemists' Association (CCA) in response to an attack by the Pharmacists' Defence Association.
Last week, PDA allegedly accused some large pharmacy chains of 'orchestrating' full or part-time closures of some of their shops due to the staff shortage.
In its Open Letter published on Tuesday (July 19), PDA demanded urgent action "to protect patients by ensuring that essential community pharmacy services are
provided safely and consistently".
"All parts of the healthcare system are struggling to recruit staff and to assume that pharmacies would be immune to such pressures, seems fanciful," said CCA.
"CCA members are working extraordinarily hard to prevent temporary closures, but recruitment and retention of pharmacists is becoming increasingly tough. The recent
rise in Covid cases and the beginning of the summer holiday season in parts of the UK have only worsened the situation."
The Association also showed data from the PSNC Pharmacy Pressures Survey (April 2022) which found that 91 per cent of pharmacies are experiencing staff shortages,
clearly demonstrating that these shortages are affecting the entire sector.
Former chancellor Rishi Sunak, one of two candidates vying to be Britain's next premier, criticised the way outgoing prime minister Boris Johnson handled the
Covid-19 pandemic, saying it had been a mistake to "empower" scientists and that the downsides of lockdowns were suppressed.
The Tories are choosing a new leader after Johnson was forced to quit when dozens of ministers resigned in protest at a series of scandals and missteps. Party members
are voting to select either Sunak or foreign secretary Liz Truss, who will take over next month.
Opinion polls show Sunak is behind in race. The handling of the pandemic has become an issue, with Truss saying this month she would never again approve another
lockdown and also asserting that as trade minister at the time she was not involved in taking the key decisions about how to respond.
Sunak said the government had been "wrong to scare people" about coronavirus. He said he was banned by officials in Johnson's office from discussing the "trade-offs"
of imposing coronavirus-related restrictions, such as the impact on missed doctor's appointments and lengthening waiting lists for healthcare in the NHS.